Table 3 Clinicopathological characteristics between patients cured or non-cured
| Â | Total (n = 33) | Non-cured (n = 17) | Cured (n = 16) |
|---|---|---|---|
Age, year, median (range) | 59 (33–75) | 59 (36–74) | 58.5 (33–75) |
Gender, n | |||
 Male | 12 | 5 | 7 |
 Female | 21 | 12 | 9 |
Timing of peritoneal metastasis, n | |||
 Synchronous | 7 | 2 | 5 |
 Metachronous | 26 | 15 | 11 |
Primary tumor location, n | |||
 Right colon | 17 | 8 | 9 |
 Left colon | 16 | 9 | 7 |
 Rectum | 0 | 0 | 0 |
Histology, n | |||
 tub | 24 | 11 | 13 |
 muc | 7 | 4 | 3 |
 sig | 2 | 2 | 0 |
Lymph node metastasis, n | |||
 Negative | 12 | 7 | 5 |
 Positive | 21 | 10 | 11 |
PCI at CRS, median (range) | 4 (1–27) | 5 (1–27) | 2 (1–8) |
 0–5 | 25 | 10 | 15 |
 6–10 | 4 | 3 | 1 |
 11–15 | 2 | 2 | 0 |
 16–20 | 1 | 1 | 0 |
  ≥ 21 | 1 | 1 | 0 |
Completeness of cytoreduction | |||
 CCR-0 | 33 | 17 | 16 |
 CCR-1 to 3 | 0 | 0 | 0 |
HIPEC, n | Â | Â | Â |
 Yes | 26 | 14 | 12 |
 No | 7 | 3 | 4 |
Postoperative complication (G ≥ 3) | |||
 Yes | 5 | 4 | 1 |
 No | 28 | 13 | 15 |
Preoperative systemic chemotherapy, n | |||
 Yes | 28 | 15 | 13 |
 No | 5 | 2 | 3 |
Preoperative intraperitoneal chemotherapy, n | |||
 Yes | 5 | 3 | 2 |
 No | 28 | 14 | 14 |
Postoperative chemotherapy, n | |||
 Yes | 28 | 16 | 12 |
 No | 5 | 1 | 4 |
Recurrence, n | |||
 Yes | 19 | 17 | 2 |
 No | 14 | 0 | 14 |